Search

Your search keyword '"Glucans toxicity"' showing total 89 results

Search Constraints

Start Over You searched for: Descriptor "Glucans toxicity" Remove constraint Descriptor: "Glucans toxicity"
89 results on '"Glucans toxicity"'

Search Results

1. Tocopheryl Phosphate Inhibits Rheumatoid Arthritis-Related Gene Expression In Vitro and Ameliorates Arthritic Symptoms in Mice.

2. Characterization of a nanoparticulate exopolysaccharide from Leuconostoc holzapfelii KM01 and its potential application in drug encapsulation.

3. Pullulan derivative with cationic and hydrophobic moieties as an appropriate macromolecule in the synthesis of nanoparticles for drug delivery.

4. Pullulan based stimuli responsive and sub cellular targeted nanoplatforms for biomedical application: Synthesis, nanoformulations and toxicological perspective.

5. Engineering butylglyceryl-modified polysaccharides towards nanomedicines for brain drug delivery.

6. Safe-by-Design of Glucan Nanoparticles: Size Matters When Assessing the Immunotoxicity.

7. Prosopis juliflora as a new cosmetic ingredient: Development and clinical evaluation of a bioactive moisturizing and anti-aging innovative solid core.

8. Pullulan dialdehyde crosslinked gelatin hydrogels with high strength for biomedical applications.

9. Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma.

10. Cytotoxic effect of a mannogalactoglucan extracted from Agaricus bisporus on HepG2 cells.

11. Phytoglycogen to increase lutein solubility and its permeation through Caco-2 monolayer.

12. An innovative polysaccharide nanobased nail formulation for improvement of onychomycosis treatment.

13. In Vitro and In Vivo Performance of Novel Spray Dried Andrographolide Loaded Scleroglucan Based Formulation for Dry Powder Inhaler.

14. A 90-day oral (dietary) toxicity and mass balance study of corn starch fiber in Sprague Dawley rats.

15. Genotoxicity and subchronic toxicity evaluation of dried Euglena gracilis ATCC PTA-123017.

16. Charged pullulan derivatives for the development of nanocarriers by polyelectrolyte complexation.

17. Safety evaluation of a newly-developed dietary fiber: resistant glucan mixture.

18. Stability, Pharmacokinetics, Biodistribution and Safety Assessment of Folate-Conjugated Pullulan Acetate Nanoparticles as Cervical Cancer Targeted Drug Carriers.

19. Nanoparticles Made From Xyloglucan-Block-Polycaprolactone Copolymers: Safety Assessment for Drug Delivery.

20. S-maltoheptaose targets syndecan-bound effectors to reduce smoking-related neutrophilic inflammation.

21. Imaging of the peritoneum evaluated by 99mTc-icodextrin scintigraphy in peritoneal dialysis patients: preliminary data.

22. Polyglucosan neurotoxicity caused by glycogen branching enzyme deficiency can be reversed by inhibition of glycogen synthase.

23. Pullulan-based nanoparticles as carriers for transmucosal protein delivery.

24. GSK-3β inhibition protects mesothelial cells during experimental peritoneal dialysis through upregulation of the heat shock response.

25. Complexation of fisetin with novel cyclosophoroase dimer to improve solubility and bioavailability.

26. Characterization and lectin microarray of an immunomodulatory heteroglucan from Pleurotus ostreatus mycelia.

27. Evaluation of tropicamide-loaded tamarind seed xyloglucan nanoaggregates for ophthalmic delivery.

28. Single dose toxicity studies of sulfated water soluble beta-D-glucan in Sprague-Dawley rats.

29. The effects of sperminated pullulans on cornea permeability to puerarin and the toxicity.

30. Impacts of icodextrin on integrin-mediated wound healing of peritoneal mesothelial cells.

31. Toxicological and immunomodulatory assessments of botryosphaeran (β-glucan) produced by Botryosphaeria rhodina RCYU 30101.

32. Immunomodulatory activities and subacute toxicity of a novel β-glucan from Paenibacillus polymyxa JB115 in rats.

33. [Effects of sperminated pullulans on the pulmonary absorption of insulin].

34. Subchronic (13-week) oral toxicity study in rats with fungal chitin-glucan from Aspergillus niger.

35. Stability and in vivo evaluation of pullulan acetate as a drug nanocarrier.

36. Self-assembled nanoparticle drug delivery systems from galactosylated polysaccharide-doxorubicin conjugate loaded doxorubicin.

37. [Non allergic disorders associated with domestic moulds].

38. Preparation of cationized polysaccharides as gene transfection carrier for bone marrow-derived mesenchymal stem cells.

39. Safety evaluation of polydextrose in infant formula using a suckling piglet model.

40. Practical induction system for dopamine-producing cells from bone marrow stromal cells using spermine-pullulan-mediated reverse transfection method.

41. Neuronal gene delivery by negatively charged pullulan-spermine/DNA anioplexes.

42. Moldy environments and toxic pneumonitis.

43. Evaluation of glucan/poly(vinyl alcohol) blend wound dressing using rat models.

44. Enhancement of the solubility and efficacy of poorly water-soluble drugs by hydrophobically-modified polysaccharide derivatives.

45. Aseptic peritonitis and icodextrin.

46. Microbial cell wall agents and sick building syndrome.

48. Repeated dose oral toxicological evaluation of concentrated barley beta-glucan in CD-1 mice including a recovery phase.

49. Aminated polysaccharide microspheres as DNA delivery systems.

50. Evaluation of the toxicity of concentrated barley beta-glucan in a 28-day feeding study in Wistar rats.

Catalog

Books, media, physical & digital resources